Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Kowa Research Institute Inc.
Sponsor

Kowa Research Institute Inc.

United States 430 Davis Drive Suite 200, 27560-6802, United States

About the sponsor

Kowa Research Institute Inc. is involved in clinical research for Fuchs endothelial corneal dystrophy, with a focus on preserving and improving visual acuity after corneal procedures. Its studies center on treatment approaches used around descemetorhexis and cataract-related surgery in patients with endothelial dysfunction.

  • Fuchs endothelial corneal dystrophy
  • Best corrected visual acuity (BCVA)
  • Descemetorhexis
  • Cataract surgery

The sponsor’s ophthalmic research includes interest in post-procedural recovery and corneal clarity in a setting of progressive endothelial cell loss.

About Specializations

Kowa Research Institute Inc. runs clinical trials in conditions such as Corneal dystrophy, Metabolic dysfunction-associated steatohepatitis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Corneal dystrophy

Not recruiting

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ripasudil
  • Sponsor:Kowa Research Institute Inc.

Metabolic dysfunction-associated steatohepatitis

Not recruiting

Study on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Pemafibrate
  • Sponsor:Kowa Research Institute Inc.

Corneal dystrophy

Not recruiting

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Dystrophy After Cataract Surgery

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ripasudil
  • Sponsor:Kowa Research Institute Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.